IDEAYA Biosciences, Inc.
IDYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $208 | $0 | $0 | $7 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $207 | -$1 | -$1 | $6 |
| % Margin | 99.5% | – | – | 90.8% |
| R&D Expenses | $83 | $74 | $71 | $140 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $15 | $13 | $12 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $98 | $88 | $83 | $150 |
| Operating Income | $108 | -$89 | -$84 | -$144 |
| % Margin | 52.2% | – | – | -2,059.1% |
| Other Income/Exp. Net | $11 | $11 | $12 | $14 |
| Pre-Tax Income | $119 | -$77 | -$72 | -$130 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $119 | -$77 | -$72 | -$130 |
| % Margin | 57.4% | – | – | -1,861.6% |
| EPS | 1.35 | -0.88 | -0.82 | -1.49 |
| % Growth | 253.4% | -7.3% | 45% | – |
| EPS Diluted | 1.33 | -0.88 | -0.82 | -1.49 |
| Weighted Avg Shares Out | 90 | 88 | 88 | 87 |
| Weighted Avg Shares Out Dil | 90 | 88 | 88 | 87 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $11 | $12 | $14 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $120 | -$76 | -$71 | -$130 |
| % Margin | 57.9% | – | – | -1,852.4% |